Results 131 to 140 of about 396,361 (329)

Outcome and safety of multiple photodynamic therapy sessions in chronic central serous chorioretinopathy

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose This study evaluates the effectiveness and safety of multiple PDT sessions for cases of persistent and recurrent subretinal fluid (SRF) in chronic central serous chorioretinopathy (CSC). Methods This multicentre, retrospective cohort study included patients aged ≥18 years with chronic CSC who received at least two sessions of PDT at ...
Jennifer M. Chang‐Wolf   +7 more
wiley   +1 more source

A fast protocol for photodynamic therapy in exudative choroidal circumscribed hemangioma: Early laser irradiance after end of verteporfin infusion

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The aim of the study is to compare the risk of first‐line photodynamic therapy (PDT) failure according to the PDT protocol performed in patients with exudative choroidal circumscribed hemangioma (CCH). Methods We retrospectively included patients from 11 European centres in France, Italy and Denmark.
Paul Dubar   +14 more
wiley   +1 more source

Hypoxia-Induced Retinal Neovascularization in Zebrafish Embryos: A Potential Model of Retinopathy of Prematurity

open access: yesPLoS ONE, 2015
Retinopathy of prematurity, formerly known as a retrolental fibroplasia, is a leading cause of infantile blindness worldwide. Retinopathy of prematurity is caused by the failure of central retinal vessels to reach the retinal periphery, creating a ...
Yu-Ching Wu   +6 more
semanticscholar   +1 more source

Neuroretinal hypoxic signaling in a new preclinical murine model for proliferative diabetic retinopathy [PDF]

open access: yes, 2016
Diabetic retinopathy (DR) affects approximately one-third of diabetic patients and, if left untreated, progresses to proliferative DR (PDR) with associated vitreous hemorrhage, retinal detachment, iris neovascularization, glaucoma and irreversible ...
Bassuk, Alexander G.   +12 more
core   +2 more sources

Calcitriol Is a Potent Inhibitor of Retinal Neovascularization

open access: yesInvestigative Opthalmology & Visual Science, 2007
Vitamin D compounds inhibit the growth of a variety of tumors in preclinical and clinical studies. Among the mechanisms suggested for this inhibition is antiangiogenesis. Retinal angiogenesis is the basis for vision loss in several major blinding diseases.
Elizabeth A. Scheef   +6 more
openaire   +2 more sources

Prevalence of central serous chorioretinopathy in Denmark

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Central serous chorioretinopathy (CSC) is a prevalent maculopathy, but epidemiological studies are few. In this study, we determined the prevalence of CSC for the first time in a Scandinavian population. Methods This cross‐sectional study was based on nationwide opportunistic retinal examination from 79 high street chain optician ...
Ida N. Frederiksen   +19 more
wiley   +1 more source

RETINAL ANGIOMATOUS PROLIFERATION: A Quantitative Analysis of the Fundoscopic Features of the Fellow Eye [PDF]

open access: yes, 2015
PURPOSE: To quantitatively analyze and compare the fundoscopic features between fellow eyes of retinal angiomatous proliferation and typical exudative age-related macular degeneration and to identify possible predictors of neovascularization. METHODS:
Costa, MA   +6 more
core   +1 more source

Intravitreal anti‐vascular endothelial growth factor injections and risks of stroke in patients with neovascular age‐related macular degeneration—A registry‐based cohort study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Background Intravitreal Anti‐Vascular Endothelial Growth Factor (VEGF) rescues retinal vasculatures and prevents disease progression in patients with neovascular Age‐Related Macular Degeneration (nAMD). However, systemic anti‐VEGF may increase the risk of thromboembolic related complications including stroke and TIA. This study aims to explore
A. H. Falemban   +5 more
wiley   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy